BLUEBELL MEDICARE LIMITED

Company Registration Number:
07318149 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

BLUEBELL MEDICARE LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2024

Balance sheet
Notes

BLUEBELL MEDICARE LIMITED

Balance sheet

As at 31 July 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 31,675 38,628
Total fixed assets: 31,675 38,628
Current assets
Debtors:   7,920 29,638
Cash at bank and in hand: 804,282 702,563
Total current assets: 812,202 732,201
Creditors: amounts falling due within one year:   (33,505) (19,288)
Net current assets (liabilities): 778,697 712,913
Total assets less current liabilities: 810,372 751,541
Creditors: amounts falling due after more than one year:   (20,755) (32,388)
Total net assets (liabilities): 789,617 719,153
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 789,517 719,053
Shareholders funds: 789,617 719,153

The notes form part of these financial statements

BLUEBELL MEDICARE LIMITED

Balance sheet statements

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 March 2025
and signed on behalf of the board by:

Name: S MURTHY
Status: Director

The notes form part of these financial statements

BLUEBELL MEDICARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BLUEBELL MEDICARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

2. Employees

2024 2023
Average number of employees during the period 3 3

BLUEBELL MEDICARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

3. Tangible Assets

Total
Cost £
At 01 August 2023 38,628
At 31 July 2024 38,628
Depreciation
At 01 August 2023 0
Charge for year 6,953
At 31 July 2024 6,953
Net book value
At 31 July 2024 31,675
At 31 July 2023 38,628